4//SEC Filing
Paul Andrea 4
Accession 0001725160-23-000016
CIK 0001725160other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 7:06 PM ET
Size
7.1 KB
Accession
0001725160-23-000016
Insider Transaction Report
Form 4
Paul Andrea
Chief Legal Officer
Transactions
- Award
Common Stock
2023-02-01+40,783→ 40,783 total - Award
Stock Option (Right to Buy)
2023-02-01+59,217→ 59,217 totalExercise: $23.65Exp: 2033-01-31→ Common Stock (59,217 underlying)
Footnotes (2)
- [F1]Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date.
- [F2]The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001863130
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 7:06 PM ET
- Size
- 7.1 KB